139 related articles for article (PubMed ID: 7738389)
1. Topical immunotherapy in children with alopecia areata.
Orecchia G; Malagoli P
J Invest Dermatol; 1995 May; 104(5 Suppl):35S-36S. PubMed ID: 7738389
[No Abstract] [Full Text] [Related]
2. Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis.
Tosti A; Guidetti MS; Bardazzi F; Misciali C
J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):199-201. PubMed ID: 8708020
[TBL] [Abstract][Full Text] [Related]
3. [Controlled study of the efficacy of topical immunotherapy in alopecia areata: squaric acid versus placebo].
Pigatto PD; Rapisarda R; Polenghi MM; Altomare GF
G Ital Dermatol Venereol; 1987 Dec; 122(12):667-70. PubMed ID: 3329149
[No Abstract] [Full Text] [Related]
4. [Sensitization therapy in severe alopecia areata].
Tosti A; Guerra L; Capobianco C; Brasile GP
G Ital Dermatol Venereol; 1988 Nov; 123(11):571-3. PubMed ID: 3254331
[No Abstract] [Full Text] [Related]
5. Topical squaric acid dibutylester therapy for alopecia areata.
Flowers FP; Slazinski L; Fenske NA; Pullara TJ
Cutis; 1982 Dec; 30(6):733-6. PubMed ID: 6756800
[No Abstract] [Full Text] [Related]
6. Topical therapy of alopecia areata with squaric acid dibutylester.
Case PC; Mitchell AJ; Swanson NA; Vanderveen EE; Ellis CN; Headington JT
J Am Acad Dermatol; 1984 Mar; 10(3):447-50. PubMed ID: 6725657
[TBL] [Abstract][Full Text] [Related]
7. Topical immunotherapy in dermatology.
Buckley DA; du Vivier AW
Int J Clin Pract; 1999 Mar; 53(2):130-7. PubMed ID: 10344049
[TBL] [Abstract][Full Text] [Related]
8. Topical immunotherapy in the treatment of chronic severe alopecia areata.
Shapiro J
Dermatol Clin; 1993 Jul; 11(3):611-7. PubMed ID: 8365043
[TBL] [Abstract][Full Text] [Related]
9. Topical immunotherapy of alopecia areata.
van der Steen PH; Happle R
Dermatol Clin; 1993 Jul; 11(3):619-22. PubMed ID: 8365044
[TBL] [Abstract][Full Text] [Related]
10. Topical immunotherapy with contact allergens in alopecia areata: evidence for non-specific systemic suppression of cellular immune reactions.
Bröcker EB; John SM; Steinhausen D; Hamm H
Arch Dermatol Res; 1991; 283(2):133-4. PubMed ID: 2069412
[No Abstract] [Full Text] [Related]
11. Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
Morita K; Nakamura M; Nagamachi M; Kishi T; Miyachi Y
J Dermatol; 2002 Oct; 29(10):661-4. PubMed ID: 12433000
[TBL] [Abstract][Full Text] [Related]
12. [In situ lymphocyte subpopulation in alopecia areata after treatment with squaric acid dibutyl ester].
Rosso R; Paulli M; Marelli MA; Douville H; Orecchia G
G Ital Dermatol Venereol; 1988 Nov; 123(11):575-7. PubMed ID: 3254332
[No Abstract] [Full Text] [Related]
13. Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study.
Chua SH; Goh CL; Ang CB
Ann Acad Med Singap; 1996 Nov; 25(6):842-7. PubMed ID: 9055014
[TBL] [Abstract][Full Text] [Related]
14. Effect of topical immunotherapy with squaric acid dibutylester for alopecia areata in Japanese patients.
Sakai K; Fukushima S; Mizuhashi S; Jinnin M; Makino T; Inoue Y; Ihn H
Allergol Int; 2020 Apr; 69(2):274-278. PubMed ID: 31767273
[TBL] [Abstract][Full Text] [Related]
15. Topical immunotherapy of alopecia areata. A follow-up study.
Valsecchi R; Cainelli T; Foiadelli L; Rossi A
Acta Derm Venereol; 1986; 66(3):269-72. PubMed ID: 2426909
[TBL] [Abstract][Full Text] [Related]
16. [Pigmentation abnormalities in the course of topical immunotherapy of alopecia areata].
Valsecchi R; Pansera B; Rossi A; Cainelli T
G Ital Dermatol Venereol; 1989; 124(1-2):31-2. PubMed ID: 2527809
[TBL] [Abstract][Full Text] [Related]
17. Alopecia areata: more on topical sensitizers.
Orecchia G; Marelli MA; Perfetti L; Rabbiosi G
Dermatologica; 1990; 180(2):57-9. PubMed ID: 2311796
[TBL] [Abstract][Full Text] [Related]
18. [Alopecia areata; pathogenesis and topical immunotherapy].
Perret CM; Steijlen PM; Happle R
Ned Tijdschr Geneeskd; 1989 Jun; 133(25):1256-60. PubMed ID: 2666865
[No Abstract] [Full Text] [Related]
19. Topical immunotherapy for alopecia areata: re-evaluation of 139 cases after an additional follow-up period of 19 months.
van der Steen PH; Boezeman JB; Happle R
Dermatology; 1992; 184(3):198-201. PubMed ID: 1392112
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for clinical response of alopecia areata to topical immunotherapy with squaric acid dibutylester.
Iijima S; Otsuka F
Arch Dermatol; 1997 Apr; 133(4):539-40. PubMed ID: 9126022
[No Abstract] [Full Text] [Related]
[Next] [New Search]